Investigación / Grupos de investigación

Grupo  1

Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Publicaciones (865)

  • Romero, M; Aguilar, JM; Del-Rey-Mejias, A; Mayora, F; Rapado, M; Pecina, M; Barbancho, MA; Ruiz-Veguilla, M; Lara, JP.

    Psychiatric comorbidities in autism spectrum disorder: A comparative study between DSM-IV-TR and DSM-5 diagnosis

    INTERNATIONAL JOURNAL OF CLINICAL AND HEALTH PSYCHOLOGY. 2016; 16(3): 266-275 Nº de citas: 87 [doi:10.1016/j.ijchp.2016.03.001]

  • Gonzalez-Pinto, A; Gonzalez-Ortega, I; Alberich, S; de Azua, SR; Bernardo, M; Bioque, M; Cabrera, B; Corripio, I; Arango, C; Lobo, A; Sanchez-Torres, AM; Cuesta, MJ.

    Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

    PLoS One. 2016; 11(8): Nº de citas: 20 [doi:10.1371/journal.pone.0160949]

  • Colom, R; Martinez, K; Burgaleta, M; Roman, FJ; Garcia-Garcia, D; Gunter, JL; Hua, X; Jaeggi, SM; Thompson, PM.

    Gray matter volumetric changes with a challenging adaptive cognitive training program based on the dual n-back task

    PERSONALITY AND INDIVIDUAL DIFFERENCES. 2016; 98: 127-132 Nº de citas: 14 [doi:10.1016/j.paid.2016.03.087]

  • Gonzalez-Penas, J; Amigo, J; Santome, L; Sobrino, B; Brenlla, J; Agra, S; Paz, E; Paramo, M; Carracedo, A; Arrojo, M; Costas, J.

    Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states

    SCHIZOPHRENIA RESEARCH. 2016; 174(1-3): 10-16 Nº de citas: 6 [doi:10.1016/j.schres.2016.03.029]

  • Farreny, A; del Rey-Mejias, A; Escartin, G; Usall, J; Tous, N; Haro, JM; Ochoa, S.

    Study of positive and negative feedback sensitivity in psychosis using the Wisconsin Card Sorting Test

    COMPREHENSIVE PSYCHIATRY. 2016; 68: 119-128 Nº de citas: 15 [doi:10.1016/j.comppsych.2016.04.011]

  • Cabrera, B; Bioque, M; Penades, R; Gonzalez-Pinto, A; Parellada, M; Bobes, J; Lobo, A; Garcia-Bueno, B; Leza, JC; Bernardo, M.

    Cognition and psychopathology in first-episode psychosis: are they related to inflammation?

    PSYCHOLOGICAL MEDICINE. 2016; 46(10): 2133-2144 Nº de citas: 39 [doi:10.1017/S0033291716000659]

  • Montejo, AL; Arango, C; Bernardo, M; Carrasco, JL; Crespo-Facorro, B; Cruz, JJ; del Pino, J; Escuderoh, MAG; Rizo, CG; Gonzalez-Pinto, A; Hernandez, AI; Carrasco, MM; Cleries, FM; van Son, JM; Mories, MT; Pachiarotti, I; Ros, S; Vieta, E.

    Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia

    SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2016; 9(3): 158-173 Nº de citas: 56 [doi:10.1016/j.rpsm.2015.11.003]

  • Fraguas, D; Diaz-Caneja, CM; Pina-Camacho, L; Janssen, J; Arango, C.

    Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies

    SCHIZOPHRENIA RESEARCH. 2016; 173(3): 132-139 Nº de citas: 56 [doi:10.1016/j.schres.2014.12.022]

  • Alda, JA; Munoz-Samons, D; Tor, J; Merchan-Naranjo, J; Tapia-Casellas, C; Baeza, I; Calvo-Escalona, R; Castro-Fornieles, J; Martinez-Cantarero, C; Andres-Nestares, P; Fernandez-Aviles, F; Arango, C.

    Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study

    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY. 2016; 26(5): 449-457 Nº de citas: 5 [doi:10.1089/cap.2015.0151]

  • Solana, AB; Martinez, K; Hernandez-Tamames, JA; San Antonio-Arce, V; Toledano, R; Garcia-Morales, I; Alvarez-Linera, J; Gil-Nagel, A; del Pozo, F.

    Altered brain rhythms and functional network disruptions involved in patients with generalized fixation-off epilepsy

    BRAIN IMAGING AND BEHAVIOR. 2016; 10(2): 373-386 Nº de citas: 6 [doi:10.1007/s11682-015-9404-6]

  • Navas-Sanchez, FJ; Carmona, S; Aleman-Gomez, Y; Sanchez-Gonzalez, J; Guzman-de-Villoria, J; Franco, C; Robles, O; Arango, C; Desco, M.

    Cortical morphometry in frontoparietal and default mode networks in math-gifted adolescents

    HUMAN BRAIN MAPPING. 2016; 37(5): 1893-1902 Nº de citas: 13 [doi:10.1002/hbm.23143]

  • Fagiolini, A; Alfonsi, E; Amodeo, G; Cenci, M; Di Lella, M; Farinella, F; Ferraiuolo, F; Fraguas, D; Loparco, N; Gutierrez-Rojas, L; Mignone, ML; Pataracchia, G; Pillai, G; Russo, F; Sanchez-Gistau, V; Spinogatti, F; Toscano, M; Villari, V; De Filippis, S.

    Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists

    EXPERT OPINION ON DRUG SAFETY. 2016; 15(4): 449-455 Nº de citas: 10 [doi:10.1517/14740338.2016.1155553]

  • Bioque, M; Cabrera, B; Garcia-Bueno, B; Mac-Dowell, KS; Torrent, C; Saiz, PA; Parellada, M; Gonzalez-Pinto, A; Lobo, A; Leza, JC; Bernardo, M.

    Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis

    JOURNAL OF PSYCHIATRIC RESEARCH. 2016; 75: 14-21 Nº de citas: 17 [doi:10.1016/j.jpsychires.2016.01.002]

  • Martin-Perez, M; De Andres, AL; Gonzalez, MAB; Jimenez-Garcia, R; Hernandez-Barrera, V; Jimenez-Trujillo, I; Palacios-Cena, D; Carrasco-Garrido, P.

    Parental administration of over-the-counter medication to Spanish children: A population-based national study

    JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING. 2016; 21(2): 64-73 Nº de citas: 5 [doi:10.1111/jspn.12141]

  • Bioque, M; Llerena, A; Cabrera, B; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Diaz-Caneja, CM; Corripio, I; Aguilar, EJ; Bulbena, A; Castro-Fornieles, J; Vieta, E; Lafuente, A; Mas, S; Parellada, M; Saiz-Ruiz, J; Cuesta, MJ; Bernardo, M.

    A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2016; 19(4): Nº de citas: 29 [doi:10.1093/ijnp/pyv121]

  • Sommer, IE; Bearden, CE; van Dellen, E; Breetvelt, EJ; Duijff, SN; Maijer, K; van Amelsvoort, T; de Haan, L; Gur, RE; Arango, C; Diaz-Caneja, CM; Vinkers, CH; Vorstman, JAS.

    Early interventions in risk groups for schizophrenia: what are we waiting for?

    SCHIZOPHRENIA. 2016; 2: 16003 Nº de citas: 112 [doi:10.1038/npjschz.2016.3]

  • Galling, B; Roldan, A; Nielsen, RE; Nielsen, J; Gerhard, T; Carbon, M; Stubbs, B; Vancampfort, D; De Hert, M; Olfson, M; Kahl, KG; Martin, A; Guo, JJ; Lane, HY; Sung, FC; Liao, CH; Arango, C; Correll, CU.

    Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics A Systematic Review and Meta-analysis

    JAMA PSYCHIATRY. 2016; 73(3): 247-259 Nº de citas: 188 [doi:10.1001/jamapsychiatry.2015.2923]

  • Pina-Camacho, L; Del Rey-Mejias, A; Janssen, J; Bioque, M; Gonzalez-Pinto, A; Arango, C; Lobo, A; Sarro, S; Desco, M; Sanjuan, J; Lacalle-Aurioles, M; Cuesta, MJ; Saiz-Ruiz, J; Bernardo, M; Parellada, M.

    Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis

    SCHIZOPHRENIA BULLETIN. 2016; 42(2): 344-357 Nº de citas: 50 [doi:10.1093/schbul/sbv128]